Close Menu

NEW YORK (GenomeWeb) – Promega said today that it has non-exclusively licensed the Broad Institute's CRISPR-Cas9 intellectual property.

Under the terms of the agreement, Promega will combine the Broad's CRISPR-Cas9 technology with its own products for knock-in of genetic reporters into the genomes of any cell or cell line. The firm is aiming to develop and sell gene editing tools and reagents for interrogating endogenous biology at physiologically relevant expression levels.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Holden Thorp is to be the new editor-in-chief of Science and its related journals.

A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.

Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.

In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.